{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-033586","form_type":"8-K","ticker":"BBLG","cik":"0001419554","company_name":"Bone Biologics Corp","filed_at":"2026-07-16T21:25:14+00:00","discovered_at":"2026-07-16T21:26:00.257401+00:00","generated_at":"2026-07-16T21:26:02.630507+00:00","sec_items":["8.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.2,"calibrated_materiality_score":0.2,"confidence":"high","headline":"Bone Biologics postpones 2026 annual meeting to September 28, 2026","bullets":["Annual meeting moved from August 11 to September 28, 2026; new record date August 6, 2026.","Board cites need for additional time for stockholders to consider proxy materials with an added proposal.","Stockholder proposal deadline extended to July 26, 2026, ten days after this 8-K filing.","Meeting location unchanged: 2 Burlington Woods Drive, Ste 100, Burlington, MA at 11:30 a.m. ET."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-033586","json":"https://secwatch.observer/filing/0001493152-26-033586.json","markdown":"https://secwatch.observer/filing/0001493152-26-033586.md","text":"https://secwatch.observer/filing/0001493152-26-033586.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226033586/0001493152-26-033586-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1419554/000149315226033586/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-16T21:26:02.630507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}